Intramuscular Administration of Recombinant Adeno-Associated Virus 2 α-1 Antitrypsin (rAAV-SERPINA1) Vectors in a Nonhuman Primate Model: Safety and Immunologic Aspects

This publication has 19 references indexed in Scilit:

• Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors
  Gene Therapy, 2001
• Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
  Nature Genetics, 2000
• Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
  Proceedings of the National Academy of Sciences, 1999
• Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
  Proceedings of the National Academy of Sciences, 1998
• Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin
  Proceedings of the National Academy of Sciences, 1997
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
  Nature Genetics, 1997
• Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
  Proceedings of the National Academy of Sciences, 1997
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
  Proceedings of the National Academy of Sciences, 1996
• The mechanism of Z α1-antitrypsin accumulation in the liver
  Nature, 1992
• The α1-antitrypsin gene and its deficiency states
  Trends in Genetics, 1989